Global Image-Guided Therapy Systems Industry: Key Statistics and Insights in 2024-2032
Image-Guided Therapy Systems Industry
Summary:
- The global image-guided therapy systems market size reached USD 5.5 Billion in 2023.
- The market is expected to reach USD 8.9 Billion by 2032, exhibiting a growth rate (CAGR) of 5.4% during 2024-2032.
- North America leads the market, accounting for the largest image-guided therapy systems market share.
- Endoscopes account for the majority of the market share in the product segment due to their widespread use in minimally invasive surgeries.
- Cardiac surgery represents the leading application segment.
- Hospitals and clinics hold the largest share in the image-guided therapy systems industry.
- The rise in rapid advancement in imaging technologies is a primary driver of the image-guided therapy systems market.
- The increasing incidence of chronic diseases, such as cancer, cardiovascular disorders, and neurological conditions, is reshaping the image-guided therapy systems market.
Industry Trends and Drivers:
- Advancements in Imaging Technologies:
The rapid advancement in imaging technologies is impelling the market growth. Continuous improvements in diagnostic imaging tools are significantly enhancing the accuracy and precision of image-guided interventions. These technologies now offer real-time visualization of internal structures, enabling more precise targeting of treatment areas and minimizing damage to surrounding tissues. The integration of artificial intelligence (AI)-driven software into these imaging modalities is further increasing their efficiency by automating image analysis and enhancing decision-making processes for surgeons and clinicians. As healthcare systems globally push for minimally invasive (MI) procedures, the demand for highly sophisticated imaging technologies that improve patient outcomes continues to rise.
- Rising Prevalence of Chronic Diseases:
The increasing incidence of chronic diseases, such as cancer, cardiovascular disorders, and neurological conditions, is driving the demand for the image-guided therapy systems. Many of these conditions require precise treatment methods that benefit from real-time imaging guidance. Moreover, cancer patients often need highly targeted therapies like radiofrequency ablation or radiation therapy, which rely on precise imaging to ensure the treatment targets only cancerous tissues while sparing healthy cells. Similarly, cardiovascular interventions, such as angioplasty or stent placements, demand a high level of precision, which image-guided systems provide. This rise in chronic disease prevalence not only increases the demand for MI treatment options but also drives innovation in the development of more advanced image-guided systems.
- Growing Demand for Minimally Invasive Surgeries:
Minimally invasive surgeries (MIS) are becoming increasingly popular due to their numerous benefits, such as reduced pain, shorter hospital stays, faster recovery times, and lower risks of complications. Image-guided therapy systems play a critical role in enabling these procedures by providing real-time visualization, which helps surgeons navigate complex anatomical structures with enhanced precision. As patient preference shifts toward less invasive treatment options, healthcare providers are investing more in technologies that support these procedures. The rising demand for MIS is particularly notable in fields, such as orthopedic, cardiovascular, and neurosurgery, where precise targeting is essential for successful outcomes. The ability of image-guided systems to offer enhanced control and visualization during these surgeries is a key factor driving their adoption.
Request for a sample copy of this report: https://www.imarcgroup.com/image-guided-therapy-systems-market/requestsample
Image-guided Therapy Systems Market Report Segmentation:
Breakup By Product:
- Ultrasound Systems
- Computed Tomography (CT) Scanners
- Positron Emission Tomography (PET)
- Endoscopes
- Magnetic Resonance Imaging (MRI)
- X-ray Fluoroscopy
- Others
Endoscopes exhibit a clear dominance in the market due to their widespread use in minimally invasive surgeries, offering real-time visualization and improved precision during procedures.
Breakup By Application:
- Cardiac Surgery
- Neurosurgery
- Orthopedic Surgery
- Urology
- Oncology Surgery
- Gastroenterology
- Others
Cardiac surgery holds the biggest market share as it extensively relies on image-guided systems for precise interventions such as angioplasty, stent placement, and ablation therapies.
Breakup By End Use:
- Hospitals and Clinics
- Ambulatory Surgical Centers
- Research and Academic Institutions
- Others
Hospitals and clinics account for the majority of the market share because they are the primary centers for performing advanced image-guided surgeries, equipped with the necessary infrastructure and skilled professionals.
Breakup By Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
North America dominates the market owing to the presence of advanced healthcare infrastructure, high adoption of cutting-edge medical technologies, and a large patient population requiring minimally invasive treatments.
Top Image-guided Therapy Systems Market Leaders:
The image-guided therapy systems market research report outlines a detailed analysis of the competitive landscape, offering in-depth profiles of major companies. Some of the key players in the market are:
- Analogic Corporation
- Brainlab AG
- FUJIFILM Holdings Corporation
- General Electric Company
- Karl Storz SE & Co. KG
- Koninklijke Philips N.V.
- Medtronic plc
- Siemens Healthineers AG
- Stryker Corporation
- Varian Medical Systems Inc.
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
About Us:
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: [email protected]
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163